Aditxt (ADTX) Revenue (2022 - 2026)

Aditxt (ADTX) recorded quarterly Revenue of $12159.0 in Q1 2026, up 2760.94% quarter-over-quarter from $425.0 in Q4 2025, and up 1094.4% on a YoY basis from $1018.0 in Q1 2025.

Aditxt (ADTX) Revenue (2022 - 2026) Analysis & Trends

Aditxt's Revenue history runs 5 years deep, the most recent figure standing at $12159.0 for Q1 2026.

  • In Q1 2026, Revenue rose 1094.4% year-over-year to $12159.0; the TTM figure through Mar 2026 stood at $14336.0 (down 74.09% YoY), while the FY2025 annual figure was $3195.0, down 97.62% from the prior year.
  • Revenue was $12159.0 for Q1 2026 at Aditxt, up from $425.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $323125.0 in Q3 2022 to a low of $425.0 in Q4 2025.
  • Historically, Revenue has averaged $101660.6 across 5 years, with a median of $79680.0 in 2024.
  • The sharpest annual moves came in 2025 and 2026: Revenue sank 98.72% in 2025, then surged 1094.4% in 2026.
  • A 5-year view of Revenue shows it stood at $185596.0 in 2022, then tumbled by 56.2% to $81297.0 in 2023, then plunged by 96.09% to $3175.0 in 2024, then slumped by 86.61% to $425.0 in 2025, then surged by 2760.94% to $12159.0 in 2026.
  • The last three Revenue figures came in at $12159.0 (Q1 2026), $425.0 (Q4 2025), and $748.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 5.21 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 306.30 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.99 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Aditxt 2,485.68 -2.16 Mn 2,868.00 12,159.00

Historic Data

Download Data
DateValue
Mar 31, 2026 12,159.00
Dec 31, 2025 425.00
Sep 30, 2025 748.00
Jun 30, 2025 1,004.00
Mar 31, 2025 1,018.00
Dec 31, 2024 3,175.00
Sep 30, 2024 6,854.00
Jun 30, 2024 44,276.00
Mar 31, 2024 79,680.00
Dec 31, 2023 81,297.00
Sep 30, 2023 124,486.00
Jun 30, 2023 220,978.00
Mar 31, 2023 218,415.00
Dec 31, 2022 185,596.00
Sep 30, 2022 323,125.00
Jun 30, 2022 214,715.00
Mar 31, 2022 210,279.00